News
A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing ...
Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...
Canadian researchers find that taking semaglutide increases the chances of developing neovascular age-related macular ...
Investigators examined GLP-1 receptor agonist real-world effectiveness and safety in kidney transplant recipients with diabetes.
GLP-1 RAs may significantly increase the risk of neovascular age-related macular degeneration in older adults with diabetes.
New research shows GLP-1 drugs may be linked to a twofold increase in the risk of wet AMD among people with diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results